Company Filing History:
Years Active: 2013-2020
Title: Weimin Li: Innovator in Tumor Treatment Compounds
Introduction
Weimin Li is a notable inventor based in Sichuan, China, recognized for his contributions to the field of medicinal chemistry. He has been instrumental in developing compounds that show promise in the treatment of tumor-related diseases, particularly lung cancer. With a total of three patents to his name, his work has significant implications for cancer therapy.
Latest Patents
Weimin Li's latest patents include innovative compounds that have demonstrated significant inhibitory effects on tumor cells. One of his notable inventions is the [1,2,4]triazolo[1,5-a]pyridine derivative and its crystalline form. This invention reveals compounds that can be utilized for the prevention and treatment of tumor-related diseases, especially lung cancer, showcasing wide application prospects. Another significant patent is the pyrazolo[3,4-d]pyrimidine derivative, which also exhibits substantial inhibitory effects on tumor cells and holds potential for similar therapeutic applications.
Career Highlights
Throughout his career, Weimin Li has worked with esteemed institutions such as Sichuan University and CDGM Glass Co., Ltd. His research and development efforts have focused on creating effective treatments for cancer, contributing to advancements in the pharmaceutical field.
Collaborations
Weimin Li has collaborated with several professionals in his field, including Yang He and Li Zhang, who have contributed to his research endeavors. Their combined expertise has enhanced the development of innovative compounds aimed at combating cancer.
Conclusion
Weimin Li's work in developing tumor treatment compounds highlights his significant role in the field of medicinal chemistry. His patents reflect a commitment to advancing cancer therapy, and his collaborations further strengthen the impact of his innovations.